OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Oncology is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Targeting immunogenic cell death in cancer	373
Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms	196
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A	110
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma	110
DNA in extracellular vesicles: biological and clinical aspects	95
Clinical utility of circulating tumor cells: an update	94
Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐X_L–BAX interaction	86
The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA	86
Radiotherapy–immunotherapy combinations – perspectives and challenges	84
Exosome‐transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2	77
Prevention and treatment of radiotherapy‐induced side effects	75
Cellular senescence in cancer: from mechanisms to detection	73
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival	71
Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS–mitochondrial fission–mitophagy axis	70
A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment	65
Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy	59
Long noncoding RNA SLC2A1‐AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway	58
Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer	58
Image guidance in radiation therapy for better cure of cancer	57
iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation	56
CircFNDC3B sequestrates miR‐937‐5p to derepress TIMP3 and inhibit colorectal cancer progression	55
Autophagy, the innate immune response and cancer	53
Technology‐driven research for radiotherapy innovation	53
Global mapping of cancers: The Cancer Genome Atlas and beyond	53
AAV‐mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response	50

Particle therapy in Europe	49
Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer	49
LncRNA NKX2‐1‐AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR‐2 signaling pathway in gastric cancer	48
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer	47
Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment	45
Provision and use of radiotherapy in Europe	45
Immune response drives outcomes in prostate cancer: implications for immunotherapy	44
LncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma	44
METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5	44
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution	44
Cancer diagnostics based on plasma protein biomarkers: hard times but great expectations	43
FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway	43
Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma	43
Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7	42
Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook	42
Enhancing cancer‐associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis	41
Classification of diffuse lower‐grade glioma based on immunological profiling	41